Baxano Surgical Company Profile (NASDAQ:BAXS)

About Baxano Surgical (NASDAQ:BAXS)

Baxano Surgical logoBaxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company's other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient's hip for use in fusion procedures.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BAXS
  • CUSIP: N/A
  • Web:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.06
  • P/E Growth: N/A
  • Dividend Yield: 1.0%
  • Net Margins: -126.01%
  • Return on Equity: -117.23%
  • Return on Assets: -56.63%

Frequently Asked Questions for Baxano Surgical (NASDAQ:BAXS)

What is Baxano Surgical's stock symbol?

Baxano Surgical trades on the NASDAQ under the ticker symbol "BAXS."

How were Baxano Surgical's earnings last quarter?

Baxano Surgical Inc (NASDAQ:BAXS) released its quarterly earnings data on Tuesday, August, 5th. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.04. Baxano Surgical had a negative net margin of 126.01% and a negative return on equity of 117.23%. View Baxano Surgical's Earnings History.

Who are some of Baxano Surgical's key competitors?

How do I buy Baxano Surgical stock?

Shares of Baxano Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Baxano Surgical's stock price today?

One share of Baxano Surgical stock can currently be purchased for approximately $0.02.

MarketBeat Community Rating for Baxano Surgical (NASDAQ BAXS)
Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  41
MarketBeat's community ratings are surveys of what our community members think about Baxano Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Baxano Surgical (NASDAQ:BAXS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Baxano Surgical (NASDAQ:BAXS)
No equities research coverage for this company has been tracked by


Earnings History for Baxano Surgical (NASDAQ:BAXS)
Earnings by Quarter for Baxano Surgical (NASDAQ:BAXS)
Earnings History by Quarter for Baxano Surgical (NASDAQ BAXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/5/2014($0.14)($0.18)ViewN/AView Earnings Details
5/8/2014($0.12)($0.19)ViewN/AView Earnings Details
3/6/2014($0.14)($0.19)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.14)($0.21)$6.90 million$3.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Baxano Surgical (NASDAQ:BAXS)
Current Year EPS Consensus Estimate: $-0.5700 EPS
Next Year EPS Consensus Estimate: $-0.4000 EPS


Dividend History for Baxano Surgical (NASDAQ:BAXS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Baxano Surgical (NASDAQ:BAXS)
Insider Trades by Quarter for Baxano Surgical (NASDAQ:BAXS)
Insider Trades by Quarter for Baxano Surgical (NASDAQ:BAXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2014Kenneth Michael RealiCEOBuy10,000$0.38$3,800.00View SEC Filing  
5/12/2014Kenneth Michael RealiCEOBuy7,050$0.71$5,005.50View SEC Filing  
12/5/2013Kenneth Michael RealiCEOBuy10,500$1.11$11,655.00View SEC Filing  
5/31/2013Roderick A YoungDirectorBuy1,340,034$2.28$3,055,277.52View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Baxano Surgical (NASDAQ:BAXS)
Latest Headlines for Baxano Surgical (NASDAQ:BAXS)
DateHeadline logo5 Stocks Under $10 Set to Soar - April 7 at 8:19 AM



Baxano Surgical (BAXS) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by Staff